B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016 Market Research Report Forecast & Opportunities

ResearchMoz added Latest Research Report titled " B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016 " to it's Large Report database.

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

Summary

Global Markets Directs, B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=810391

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
B-Cell Chronic Lymphocytic Leukemia Overview 10
Therapeutics Development 11
Pipeline Products for B-Cell Chronic Lymphocytic Leukemia - Overview 11
Pipeline Products for B-Cell Chronic Lymphocytic Leukemia - Comparative Analysis 12
B-Cell Chronic Lymphocytic Leukemia - Therapeutics under Development by Companies 13
B-Cell Chronic Lymphocytic Leukemia - Therapeutics under Investigation by Universities/Institutes 15
B-Cell Chronic Lymphocytic Leukemia - Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
B-Cell Chronic Lymphocytic Leukemia - Products under Development by Companies 19
B-Cell Chronic Lymphocytic Leukemia - Products under Investigation by Universities/Institutes 21
B-Cell Chronic Lymphocytic Leukemia - Companies Involved in Therapeutics Development 22
AB Science SA 22
Aduro BioTech, Inc. 23
Amgen Inc. 24
Celgene Corporation 25

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG